TriSalus Life Sciences, Inc.
TLSI
$5.53
$0.030.55%
| Weiss Ratings | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.84 | |||
| Price History | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.47% | |||
| 30-Day Total Return | -3.32% | |||
| 60-Day Total Return | 10.16% | |||
| 90-Day Total Return | 34.22% | |||
| Year to Date Total Return | 11.04% | |||
| 1-Year Total Return | -43.57% | |||
| 2-Year Total Return | -46.26% | |||
| 3-Year Total Return | -43.63% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -47.22% | |||
| 52-Week Low % Change | 57.14% | |||
| Price | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.42 | |||
| 52-Week Low Price | $3.50 | |||
| 52-Week Low Price (Date) | Dec 10, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 172.04M | |||
| Enterprise Value | 187.14M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.50 | |||
| Earnings Per Share Growth | -97.76% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.42 | |||
| Price/Book (Q) | -8.20 | |||
| Enterprise Value/Revenue (TTM) | 6.96 | |||
| Price | $5.53 | |||
| Enterprise Value/EBITDA (TTM) | -4.20 | |||
| Enterprise Value/EBIT | -4.13 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 26.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 442 1222 | |||
| Address | 6272 West 91st Avenue Westminster, CO 80031 | |||
| Website | trisaluslifesci.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -168.46% | |||
| Profit Margin | -206.23% | |||
| Management Effectiveness | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -92.78% | |||
| Return on Equity | -- | |||
| Income Statement | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 26.89M | |||
| Total Revenue (TTM) | 26.89M | |||
| Revenue Per Share | $1.01 | |||
| Gross Profit (TTM) | 23.42M | |||
| EBITDA (TTM) | -44.55M | |||
| EBIT (TTM) | -45.30M | |||
| Net Income (TTM) | -55.46M | |||
| Net Income Avl. to Common (TTM) | -55.46M | |||
| Total Revenue Growth (Q YOY) | 41.52% | |||
| Earnings Growth (Q YOY) | -68.35% | |||
| EPS Diluted (TTM) | -2.50 | |||
| EPS Diluted Growth (Q YOY) | 15.47% | |||
| Balance Sheet | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.29M | |||
| Cash Per Share (Q) | $0.43 | |||
| Total Current Assets (Q) | 23.81M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -20.43M | |||
| Current Ratio (Q) | 2.400 | |||
| Book Value Per Share (Q) | -$0.67 | |||
| Total Assets (Q) | 27.48M | |||
| Total Current Liabilities (Q) | 9.92M | |||
| Total Debt (Q) | 23.45M | |||
| Total Liabilities (Q) | 47.91M | |||
| Total Common Equity (Q) | -20.43M | |||
| Cash Flow | TLSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -995.00K | |||
| Cash from Financing (TTM) | 34.99M | |||
| Net Change in Cash (TTM) | -10.00M | |||
| Levered Free Cash Flow (TTM) | -31.44M | |||
| Cash from Operations (TTM) | -43.99M | |||
